----
Q3 FY2026 EarningsQ3 FY26 results beat consensus on both top and bottom lines: revenue of $2,024.8M vs. $1,978.6M expected, and adjusted EPS of $0.86 slightly exceeding the $0.85 consensus. The top-line growth (+17.4% YoY) was primarily fueled by the McCormick de Mexico acquisition (14.6% contribution) and strong pricing, while organic volume fell 0.3%. Despite significant special charges of $0.50 per share related to transaction costs and impairments, McCormick reaffirmed its full-year 2026 outlook, signaling confidence in AI-driven productivity and the pending Unilever Foods merger.
Financial report interval: 2026.05.31 - 2026.08.31
Overview: McCormick & Co MD(MKC.V) the Revenue is 2.025 B (+17.39%), Beat estimate;the EBIT is 358.5 M (+22.1%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
2.02B17.39%
1.98B14.71%
+0.05B2.68%
EBITExceed expectations
0.36B22.10%
0.32B10.23%
+0.03B11.87%
Upcoming earnings report - Annual FY2026
Available dateJan 22, 2027
Estimate Revenue$7.922 B
Estimate EBIT$1.299 B
Estimate EPS--
Revenue
ActualEstimateUnit: USD
Quarterly
EBIT
ActualEstimateUnit: USD
Quarterly
Net income
ActualEstimateUnit: USD
Quarterly
EPS
ActualEstimateUnit: USD
Quarterly
